Financial Services
UMAX Group Corp.(UMAX)
Live Price
Offline$0.0002
+0.00% today
1Y Change
+100.00%
Window
Jun 20, 2025 → Jun 12, 2026
- Market Cap
- —
- Revenue Growth
- -23.2%
- EPS Growth
- -102.3%
- Dividend Yield
- 0.0%
Coverage: 249 bars · Jun 20, 2025 → Jun 12, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
UMAX Group Corp. (UMAX) is a Financial Services stock with listed on OTC. The stock last traded around $0.00 and up 100.0% across the available one-year price window (Jun 20, 2025 → Jun 12, 2026). Baseline metrics include revenue growth of -23.2%, EPS growth of -102.3%, a dividend yield of 0.0%. What stands out right now is revenue -23.2%, EPS -102.3%, free cash flow -101.5% with operating margin -819.9% and ROIC -30.4%. Valuation is more restrained than many high-expectation growth names at price/sales 0.0. Overall, the current profile looks closer to a turnaround or cyclical reset than a generic broad-market placeholder. Stock Foundry combines UMAX price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Financial Services peers on this page.
Sector Context
How this name stacks up against nearby peers on first-pass metrics.
Revenue Growth
Below sector median
-23.2% vs +3.4% peer median
Operating Margin
Below sector median
-819.9% vs +4.7% peer median
What Changed This Quarter
Latest report context and the signals most likely to have changed the story.
The operating picture looks softer than before
Revenue is at -23.2% and EPS is at -102.3%, with operating margin around -819.9%.
Benchmark Comparison
Normalized Performance vs SPY
Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.
UMAX
—
Normalized return
SPY
—
S&P 500
Excess Return
—
Relative to SPY
UMAX Max Drawdown
-50.00%
Trailing 1Y
SPY Max Drawdown
—
Trailing 1Y
Calendar-Year Returns
Uses the longest available daily history for UMAX and SPY.
Company Overview
UMAX Group Corp.
Other OTC
UMAX Group Corp., a development stage company, doing business as UMAX Nutrition, focuses on developing and distributing natural and organic nutrition, and dietary supplements to the nutritional industry. Its product line provides dietary needs for weight loss, colon health, sexual health, body building, and general health and vitality. The company's products include UPRITE XXL, a natural herbal male enhancement supplement providing an alternative to prescription erectile dysfunction medication; green coffee bean extract; and RASPBERRY KETONE, an anti-oxidant and fat burning ingredient. UMAX Group Corp. was founded in 2011 and is based in Los Angeles, California.
- Leadership
- Gerald Edick
- IPO Date
- Jan 8, 2021
- Street Address
- 3923 West 6th Street
- Mailing
- Los Angeles, CA, 90020
- Region
- Los Angeles, CA, US
- Reporting Currency
- USD
- Investor Line
- 213 381 6627
- Last Updated
- May 5, 2026
Key Fundamentals
Valuation, growth, profitability, and balance sheet signals.
Valuation
- P/E
- —
- EV/EBITDA
- —
- Price/Sales
- 0.0
- Price/Book
- —
Growth
- Revenue
- -23.2%
- EPS
- -102.3%
- Free Cash Flow
- -101.5%
Profitability
- Gross Margin
- -118.8%
- Operating Margin
- -819.9%
- Net Margin
- -848.0%
- ROE
- 29.4%
- ROIC
- -30.4%
Balance Sheet
- Debt/Equity
- —
- Current Ratio
- 0.00
Earnings Reports
Latest News
Official Releases
Company announcements and filings-style updates.
Next Step
Keep the research moving
After the overview, the strongest next step is usually chart context or a tighter compare set.